10 November 2022 – Congratulations to ARS Pharmaceuticals on their five accepted poster presentations at the 2022 American College of Allergy, Asthma and Immunology Annual Scientific Meeting. PLC has supported ARS with neffy’s clinical development and Regulatory filings since the early development phases. Recently, PLC filed an NDA with the US FDA and an MAA